Vertex Pharmaceuticals (VRTX) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist

481.855
-1.455-0.30%

Trading Mar 4 10:59 ET

123.74BMarket Cap-231.66P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Live Stock News: -2.8% GDP, Trade War Sends Market Lower, Tesla Sales Punished
Kevin Travers24minutes ago
Live Stock News: Chips Falling Alongside Crypto Despite Trump Money News-- the Honeymoon is Over
Kevin Travers11:21 ET
Play Defense With Goldman's Cheap Healthcare Picks
Seeking AlphaMar 2 12:27 ET
Vertex Pharmaceuticals Insider Sold Shares Worth $610,560, According to a Recent SEC Filing
MT NewswiresFeb 28 16:31 ET
Wall Street Today: Market Ends Wild Political TV Day in the Green
Kevin TraversFeb 28 15:38 ET
Express News | Vertex Receives Chmp Positive Opinion for Expanded Label for Kaftrio® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations
ReutersFeb 28 07:22 ET

Comments

Teddy123

Jan 31 01:16

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

$Vertex Pharmaceuticals (VRTX.US)$
Revolutionary Gene Therapy CASGEVY Now Available Through NHS England: Major Win for Sickle Cell Patients

Teddy123

Jan 30 23:42

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

$Vertex Pharmaceuticals (VRTX.US)$
FDA Approves First Non-Opioid Pain Drug in 20 Years: Vertex's Game-Changing Alternative to Opioids

Stock_Drift

Jan 30 19:13

$Vertex Pharmaceuticals (VRTX.US)$

Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller

Lnova

Jan 28 03:25

$Vertex Pharmaceuticals (VRTX.US)$ am watching this one to see the outcome biopharmcatalys...
has options
“Suzetrigine: The FDA has assigned a PDUFA target action date of January 30, 2025, for suzetrigine for the treatment of moderate-to-severe acute pain. Suzetrigine was granted Priority Review by the FDA.
The Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act became effective on January 1st, 2025. The NOPAIN Act mandates that Medicare provide a separate add-on payment in the hospital outp...

101721316

Dec 29, 2024 04:21

$Vertex Pharmaceuticals (VRTX.US)$ long term play

VRTX Vertex Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks